Though CD44 was implied as a homing receptor [56], Sheridan et al. found that the CD44+/CD24− phenotype is not enough for homing of cancer cells at the site of metastasis and its proliferation, implying the need for other factors for successful metastasis [65]. This evidence concerns the gene CD44 and cancer.